We are live on ! Find out more
INSY

Insys Therapeutics, Inc.
INSY

Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

38 hedge funds and large institutions have $48.1M invested in Insys Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+38
Holders Change %
–
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
1
BlackRock Advisors
Delaware
$6.33M +$5.03M +1,372,218 New
EA
2
Emerald Advisers
Pennsylvania
$5.71M +$4.54M +1,238,088 New
JP Morgan Chase
3
JP Morgan Chase
New York
$5.35M +$4.25M +1,159,587 New
PI
4
Putnam Investments
Massachusetts
$5.16M +$4.1M +1,118,133 New
BC
5
Broadfin Capital
New York
$4.15M +$3.3M +900,000 New
RA
6
Royce & Associates
New York
$3.46M +$2.75M +750,000 New
Wells Fargo
7
Wells Fargo
California
$3.21M +$2.55M +696,564 New
EMFAT
8
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.02M +$2.4M +655,143 New
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$2.08M +$1.65M +450,000 New
BG
10
BlackRock Group
United Kingdom
$1.96M +$1.56M +424,800 New
BFA
11
BlackRock Fund Advisors
California
$1.75M +$1.39M +378,585 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$1.16M +$918K +250,527 New
NFA
13
Nationwide Fund Advisors
Ohio
$882K +$701K +191,184 New
BIT
14
BlackRock Institutional Trust
California
$865K +$687K +187,449 New
Deutsche Bank
15
Deutsche Bank
Germany
$732K +$583K +159,057 New
GH
16
GAM Holding
Switzerland
$387K +$308K +83,940 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$297K +$236K +64,341 New
Northern Trust
18
Northern Trust
Illinois
$271K +$215K +58,638 New
Morgan Stanley
19
Morgan Stanley
New York
$222K +$177K +48,177 New
TCIM
20
TIAA CREF Investment Management
New York
$202K +$161K +43,848 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$197K +$157K +42,720 New
BIM
22
BlackRock Investment Management
Delaware
$182K +$145K +39,483 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$122K +$97K +26,472 New
Bank of America
24
Bank of America
North Carolina
$95K +$75.3K +20,547 New
TA
25
Teachers Advisors
New York
$84K +$66.8K +18,222 New
1
2

INSY Hedge Fund Activity: Q2 2013 in Review

38 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Insys Therapeutics, Inc. (INSY) for Q2 2013, worth a combined $48.1M.

Buyers outnumbered sellers: 38 funds opened new INSY positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.

  • 38 institutional investors held Insys Therapeutics, Inc. (INSY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $48.1M of Insys Therapeutics, Inc. stock for Q2 2013.
  • 38 funds opened new Insys Therapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +38 holders.

Based on aggregated 13F filings for Q2 2013.